Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2/3 1Phase 1/2 1

Status

Completed 2Not yet recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Pancreatic Neoplasms 11Colorectal Neoplasms 3Resectable Pancreatic Cancer 1Pancreatic Cancer Metastatic 1Neoplasms, Basal Cell 1Locally Advanced Unresectable or Metastatic Solid Tumors 1Localized Pancreatic Adenocarcinoma 1Gastroesophageal Adenocarcinoma 1Colorectal Cancer Metastatic 1Biliary Tract Neoplasms 1

Interventions

Bevacizumab 119Fluorouracil 91Leucovorin 83Cetuximab 83Oxaliplatin 80pembrolizumab 71Irinotecan 67Nivolumab 45Capecitabine 43Specimen Handling 40regorafenib 30trifluridine tipiracil drug combination 29Folfox protocol 29Magnetic Resonance Spectroscopy 27Biopsy 27Panitumumab 26Standard of Care 25HMPL-013 25IFL protocol 20Gemcitabine 20Trifluridine 19Cisplatin 19Blood Specimen Collection 19tislelizumab 17atezolizumab 17Carboplatin 17balstilimab 16Colonoscopy 16encorafenib 15Paclitaxel 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Colorectal Neoplasms × folfirinox × 1 year × Clear all
NCT03828799 2026-02-27

FOLFIRINOX-R

Institut du Cancer de Montpellier - Val d'Aurelle

Phase 1/2 Completed
13 enrolled 22 charts
Gastrointestinal

Colorectal Neoplasms

NCT00208260 2026-02-05

Intensified Chemotherapy in CRC After Resection of Liver Metastases

Institut du Cancer de Montpellier - Val d'Aurelle

Phase 2/3 Completed
124 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT07340567 2026-01-14

CIRCULATEIII

UNICANCER

Phase 3 Not yet recruiting
2,450 enrolled
Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡